{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:45:26Z","timestamp":1782866726535,"version":"3.54.5"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Diagnostica Stago"},{"name":"ECAT Foundation"},{"name":"Good Biomarker Sciences"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Levels of hemostasis factors vary between and within individuals as a result of genetic and environmental factors and analytical variation of the assays. The current state of the art for defining analytical precision requirements for analytical testing is based on this between- and within-individual (biological) variation. However, information on biological variation in hemostasis variables is still limited.<\/jats:p>\n                  <jats:p>The aim of this study was to determine the biological variation of coagulation variables involved in thrombosis and bleeding to provide a recommendation for performance specifications and to assess whether hemostasis assays fulfill the recommendation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We performed a longitudinal study by repeated blood sampling (in total 13 times over a 1-year period) in 40 healthy individuals and measured prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen, antithrombin, factor VIII, factor IX, von Willebrand factor (VWF), protein C, and protein S. We evaluated the effect of the biological variation on parameters of analytical variation and propose required performance specifications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Biological variation was highly different for various hemostasis variables: the within-subject variation ranged from 2.6% (PT) to 25.6% [VWF collagen binding (CB) activity], the between-subject variation varied from 4.1% (PT) to 31.2% (VWF:ristocetin cofactor acitivity), and the assay variation from 1.3% (PT) to 12.9% (VWF:CB).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>With the reagents and analyzers used in this study, most of the hemostasis tests variables fulfill the current quality criteria for diagnosis and monitoring of routine hemostasis assays.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1373\/clinchem.2016.261248","type":"journal-article","created":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T23:09:04Z","timestamp":1475017744000},"page":"1639-1646","source":"Crossref","is-referenced-by-count":45,"title":["Biological Variation of Hemostasis Variables in Thrombosis and Bleeding: Consequences for Performance Specifications"],"prefix":"10.1093","volume":"62","author":[{"given":"Moniek P M","family":"de Maat","sequence":"first","affiliation":[{"name":"Department of Haematology, Erasmus Medical Center, Rotterdam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"van Schie","sequence":"first","affiliation":[{"name":"Department of Haematology, Erasmus Medical Center, Rotterdam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"Kluft","sequence":"first","affiliation":[{"name":"ECAT Foundation, Voorschoten, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank W G","family":"Leebeek","sequence":"first","affiliation":[{"name":"Department of Haematology, Erasmus Medical Center, Rotterdam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Meijer","sequence":"first","affiliation":[{"name":"ECAT Foundation, Voorschoten, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"2020022605361435100_B1","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/clinchem\/28.9.1982","article-title":"Estimating biological variation in diagnostic tests","volume":"28","author":"Dix","year":"1982","journal-title":"Clin Chem"},{"key":"2020022605361435100_B2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1939-165X.2012.00414.x","article-title":"Subject-based reference values: biological variation, individuality, and reference change values","volume":"41","author":"Walton","year":"2012","journal-title":"Vet Clin Pathol"},{"key":"2020022605361435100_B3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cccn.2004.03.022","article-title":"Integration of data derived from biological variation into the quality management system","volume":"346","author":"Ricos","year":"2004","journal-title":"Clin Chim Acta"},{"key":"2020022605361435100_B4","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1515\/cclm-2015-0067","article-title":"Defining analytical performance specifications: consensus statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine","volume":"53","author":"Sandberg","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"2020022605361435100_B5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/10408368909106595","article-title":"Generation and application of data on biological variation in clinical chemistry","volume":"27","author":"Fraser","year":"1989","journal-title":"Crit Rev Lab Sci"},{"key":"2020022605361435100_B6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/000456329703400103","article-title":"Proposals for setting generally applicable quality goals solely based on biology","volume":"34","author":"Fraser","year":"1997","journal-title":"Ann Clin Biochem"},{"key":"2020022605361435100_B7","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1538-7836.2009.03488.x","article-title":"Biological variation in inflammatory and hemostatic markers","volume":"7","author":"Rudez","year":"2009","journal-title":"J Thromb Haemost"},{"key":"2020022605361435100_B8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1055\/s-0028-1104541","article-title":"Biological variation in tests of hemostasis","volume":"34","author":"Banfi","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"2020022605361435100_B9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/00365519950185229","article-title":"Current databases on biological variation: pros, cons and progress","volume":"59","author":"Ricos","year":"1999","journal-title":"Scand J Clin Lab Invest"},{"key":"2020022605361435100_B10","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/01.ATV.16.9.1156","article-title":"Interindividual and intraindividual variability in plasma fibrinogen, tPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris","volume":"16","author":"de Maat","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2020022605361435100_B11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-0029-1214145","article-title":"Circadian variation within hemostasis: an underrecognized link between biology and disease?","volume":"35","author":"Montagnana","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"2020022605361435100_B12","first-page":"416","article-title":"Proposed goals for analytical precision and accuracy in single-point diagnostic testing. Theoretical basis and comparison with data from College of American Pathologists proficiency surveys","volume":"112","author":"Harris","year":"1988","journal-title":"Arch Pathol Lab Med"},{"key":"2020022605361435100_B13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1055\/s-0034-1543994","article-title":"Biological and analytical variations of 16 parameters related to coagulation screening tests and the activity of coagulation factors","volume":"41","author":"Chen","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"2020022605361435100_B14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/000456329202900409","article-title":"Within-subject and between-subject biological variation of prothrombin time and activated partial thromboplastin time","volume":"29","author":"Dot","year":"1992","journal-title":"Ann Clin Biochem"},{"key":"2020022605361435100_B15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/1047-2797(92)90017-K","article-title":"Short-term intraindividual variability in hemostasis factors the ARIC study","volume":"2","author":"Chambless","year":"1992","journal-title":"Ann Epi"},{"key":"2020022605361435100_B16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1055\/s-0037-1615104","article-title":"Intra- and interindividual variability of hemostatic factors and traditional cardiovascular risk factors in a three-year follow-up","volume":"79","author":"Salomaa","year":"1998","journal-title":"Thromb Haemost"},{"key":"2020022605361435100_B17","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1055\/s-0038-1646059","article-title":"Sources of variability in coagulation factor assays","volume":"58","author":"Thompson","year":"1987","journal-title":"Thromb Haemost"},{"key":"2020022605361435100_B18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1515\/CCLM.2004.015","article-title":"Analytical goals for coagulation tests based on biological variation","volume":"42","author":"Wada","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"2020022605361435100_B19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.11613\/BM.2014.015","article-title":"Biological variations of ADAMTS13 and von Willebrand factor in human adults","volume":"24","author":"Kilercik","year":"2014","journal-title":"Biochem Med"},{"key":"2020022605361435100_B20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-0038-1653761","article-title":"ARIC Hemostasis Study\u2013IV. Intraindividual variability and reliability of hemostatic factors. The Atherosclerosis Risk In Communities (ARIC)","volume":"73","author":"Nguyen","year":"1995","journal-title":"Thromb Haemost"},{"key":"2020022605361435100_B21","first-page":"405","article-title":"Short-term and long-term intra-individual variations and critical differences of coagulation parameters","volume":"23","author":"Costongs","year":"1985","journal-title":"J Clin Chem Clin Biochem"},{"key":"2020022605361435100_B22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00001721-200106000-00002","article-title":"Stability of coagulation proteins in frozen plasma","volume":"12","author":"Woodhams","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2020022605361435100_B23","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1161\/STROKEAHA.110.586289","article-title":"High von Willebrand factor levels increase the risk of stroke: the Rotterdam study","volume":"41","author":"Wieberdink","year":"2010","journal-title":"Stroke"},{"key":"2020022605361435100_B24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/clinchem\/27.3.493","article-title":"A multi-rule shewhart chart for quality control in clinical chemistry","volume":"27","author":"Westgard","year":"1981","journal-title":"Clin Chem"},{"key":"2020022605361435100_B25","unstructured":"SAS\/STAT\u00ae 9.2 user's guide: the NESTED procedure (book excerpt). https:\/\/support.sas.com\/documentation\/cdl\/en\/statugnested\/61810\/PDF\/default\/statugnested.pdf (Accessed September 2016)."},{"key":"2020022605361435100_B26","first-page":"374","article-title":"Statistical principles underlying analytic goal-setting in clinical chemistry","volume":"72","author":"Harris","year":"1979","journal-title":"Am J Clin Pathol"},{"key":"2020022605361435100_B27","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/clinchem\/16.12.1028","article-title":"Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. 3. Physiological and medical implications","volume":"16","author":"Cotlove","year":"1970","journal-title":"Clin Chem"},{"key":"2020022605361435100_B28","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1515\/cclm-2015-0303","article-title":"Defining analytical performance specifications 15 years after the Stockholm conference","volume":"53","author":"Panteghini","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"2020022605361435100_B29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/00365519950185210","article-title":"General strategies to set quality specifications for reliability performance characteristics","volume":"59","author":"Fraser","year":"1999","journal-title":"Scand J Clin Lab Invest"},{"key":"2020022605361435100_B30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.11613\/BM.2014.036","article-title":"Could light meal jeopardize laboratory coagulation tests?","volume":"24","author":"Lima-Oliveira","year":"2014","journal-title":"Biochem Med"},{"key":"2020022605361435100_B31","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/clinchem\/48.7.1011","article-title":"Long-term analytical performance of hemostasis field methods as assessed by evaluation of the results of an external quality assessment program for antithrombin","volume":"48","author":"Meijer","year":"2002","journal-title":"Clin Chem"},{"key":"2020022605361435100_B32","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1046\/j.1538-7836.2003.00141.x","article-title":"The long-term within- and between-laboratory variability for assay of antithrombin, and proteins C and S: results derived from the external quality assessment program for thrombophilia screening of the ECAT Foundation","volume":"1","author":"Meijer","year":"2003","journal-title":"J Thromb Haemost"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/62\/12\/1639\/32645357\/clinchem1639.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/62\/12\/1639\/32645357\/clinchem1639.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T05:39:10Z","timestamp":1582695550000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/62\/12\/1639\/5612066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,1]]},"published-print":{"date-parts":[[2016,12,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2016.261248","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,12,1]]},"published":{"date-parts":[[2016,12,1]]}}}